Skip to main content

Table 2 The DVH-based parameters of the OARs in the study

From: Feasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy in patients with limited-disease small cell lung cancer

 

mean ± SD

Total lungs

 

 MLD (Gy)a

14.8 ± 1.7

 V5 (%)b

67.4 ± 9.0

 V10 (%)b

53.5 ± 7.2

 V20 (%)b

28.7 ± 3.2

 V30 (%)b

17.1 ± 2.6

Ipsilateral lungs

 

 MLD (Gy)

22.1 ± 4.1

 V5 (%)

79.1 ± 10.7

 V10 (%)

70.7 ± 11.8

 V20 (%)

47.2 ± 11.3

 V30 (%)

30.3 ± 10.0

Contralateral lungs

 

 MLD (Gy)

8.8 ± 2.9

 V5 (%)

53.1 ± 13.1

 V10 (%)

32.1 ± 12.7

 V20 (%)

11.8 ± 8.8

 V30 (%)

5.2 ± 4.6

Spinal cord

 

 Dmax (Gy)e

42.7 ± 3.7

Heart

 

 Dmean (Gy)a

16.1 ± 7.3

 V30 (%)c

23.3 ± 15.0

 V40 (%)c

9.0 ± 5.0

Esophagus

 

 MED (Gy)a

29.0 ± 6.7

 V45 (%)d

33.6 ± 5.3

  1. Abbreviations: SD standard deviation.aThe mean irradiation dose that the lung, heart and esophagus received, respectively; bthe volume of the lung that received the 5, 10, 20 and 30Gy irradiation dose, respectively; cthe volume of the heart that received 30 and 40Gy irradiation dose, respectively; dthe volume of the esophagus that received 45Gy irradiation dose; ethe maximum irradiation dose that spinal cord received.